Study highlights lack of VC funding in emerging markets

A recent article in Nature Biotechnology highlighted a lack of venture capital (VC) funding in certain emerging markets. The authors estimated that from 2000 to 2012, innovative VC and PE financing for Chinese, Indian, Brazilian and South African research-based companies totalled $1.7 billion – this is in comparison to the $1.1 billion of VC investment US research companies received in …

Investing in #vaccine biotechs? See 25 selected companies in one go

The industry's largest vaccine research and business development congress, 12th World Vaccine Congress Washington, taking place from 10-13 April at the Gaylord Convention Center, Maryland, USA is offering you first mover advantage when assessing the sectors' most promising research and technology biotech's. On 10th April 2012, 25 of the vaccine industry's most promising Biotech's will be pitching their pre-clinical, phase …